Human Stem Cells Institute (ISKJ):企業の財務・戦略的SWOT分析

◆英語タイトル:Human Stem Cells Institute (ISKJ) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH194414FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ロシア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Human Stem Cells Institute (HSCI) is a biotech company that provides discovery, research and development, and marketing of proprietary products and services in the areas of regenerative medicine, medical genetics, bio-insurance, gene therapy and biopharmaceutics. The company offers neovasculgen, a gene-therapy drug for treatment of peripheral arterial disease including critical limb ischemia; and SPRS-therapy, a set of personalized diagnostics and treatment procedures for repairing skin damage. Its neovasculgen is a gene-therapy drug, which is used in the treatment of peripheral arterial disease. HSCI also provides gemacell, a cell-based drug candidate for the treatment of myocardial infarction; and prenetix, a non-invasive prenatal diagnosis of fetal chromosome abnormalities. It owns and operates a reproductive cell and tissue bank for personal storage and donation. HSCI is headquartered in Moscow, Russia.

This comprehensive SWOT profile of Human Stem Cells Institute provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Human Stem Cells Institute including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Human Stem Cells Institute – Key Information
Human Stem Cells Institute – Overview
Human Stem Cells Institute – Key Employees
Human Stem Cells Institute – Key Employee Biographies
Human Stem Cells Institute – Key Operational Heads
Human Stem Cells Institute – Major Products and Services
Human Stem Cells Institute – History
Human Stem Cells Institute – Company Statement
Human Stem Cells Institute – Locations And Subsidiaries
Human Stem Cells Institute
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Human Stem Cells Institute – Business Description
Human Stem Cells Institute – Corporate Strategy
Human Stem Cells Institute – SWOT Analysis
SWOT Analysis – Overview
Human Stem Cells Institute – Strengths
Human Stem Cells Institute – Weaknesses
Human Stem Cells Institute – Opportunities
Human Stem Cells Institute – Threats
Human Stem Cells Institute – Key Competitors

Section 3 – Company Financial Performance Charts

Human Stem Cells Institute – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Human Stem Cells Institute, Key Information
Human Stem Cells Institute, Key Ratios
Human Stem Cells Institute, Share Data
Human Stem Cells Institute, Major Products and Services
Human Stem Cells Institute, History
Human Stem Cells Institute, Key Employees
Human Stem Cells Institute, Key Employee Biographies
Human Stem Cells Institute, Key Operational Heads
Human Stem Cells Institute, Other Locations
Human Stem Cells Institute, Subsidiaries
Human Stem Cells Institute, Key Competitors
Human Stem Cells Institute, SWOT Analysis
Human Stem Cells Institute, Ratios based on current share price
Human Stem Cells Institute, Annual Ratios
Human Stem Cells Institute, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Human Stem Cells Institute (ISKJ):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aksa Enerji Uretim AS (AKSEN):電力:M&Aディール及び事業提携情報
    Summary Aksa Enerji Uretim A.S. (Aksa Enerji), a subsidiary of Kazanci Holding A.S., is an independent power generation company. The company produces electricity through natural gas, fuel oil, hydro and wind power plants. Apart from power generation and sale, it also provides services such as projec …
  • Foundation for Innovative New Diagnostics:医療機器:M&Aディール及び事業提携情報
    Summary Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured …
  • Ausgrid:企業の戦略的SWOT分析
    Ausgrid - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Johnson & Johnson Vision Care Inc:医療機器:M&Aディール及び事業提携情報
    Summary Johnson & Johnson Vision Care Inc (J&J Vision Care), a subsidiary of Johnson & Johnson, is a medical device company that manufactures and markets contact lens and spectacle products. The company offers products such as disposable contact lens; contact lenses with astigmatism; contact lenses …
  • Oryx Petroleum Corp Ltd (OXC):石油・ガス:M&Aディール及び事業提携情報
    Summary Oryx Petroleum Corp Ltd (Oryx Petroleum), a subsidiary of The Addax and Oryx Group Ltd, is an upstream company that explores oil and gas. The company explores, develops and produces natural resources. It holds interests in petroleum license areas in Africa and the Middle East. Oryx Petroleum …
  • Scomi Group Bhd (SCOMI):企業の財務・戦略的SWOT分析
    Scomi Group Bhd (SCOMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Grupo Grana y Montero SAA (GRAMONC1):企業の財務・戦略的SWOT分析
    Grupo Grana y Montero SAA (GRAMONC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Cara Therapeutics Inc (CARA):企業の財務・戦略的SWOT分析
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruritus. Its lead product candidate includes …
  • Kadimastem Ltd (KDST):企業の財務・戦略的SWOT分析
    Summary Kadimastem Ltd (Kadimastem) is a clinical stage biopharmaceutical company that develops industrial regenerative medicines to treat neuro-degenerative diseases. Its technology platform enables the manufacturing of islet-like endocrine cells (differentiated cells) and glia restricted progenito …
  • UCB SA (UCB):企業の財務・戦略的SWOT分析
    UCB SA (UCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Lotus Bakeries NV:企業の戦略・SWOT・財務情報
    Lotus Bakeries NV - Strategy, SWOT and Corporate Finance Report Summary Lotus Bakeries NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • University of British Columbia-製薬・医療分野:企業M&A・提携分析
    Summary University of British Columbia (UBC) is a research institute that offers educational services. The university provides undergraduate, graduate educational programs, and research programs through its schools and faculties. It provides cultural, recreational and social activities for its stude …
  • Promethera Biosciences SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Promethera Biosciences SA (Promethera) is a developer of cell therapy products for the treatment of liver diseases. The company provides products which are developed on its proprietary progenitor cell type. It offers products such as promethera hepastem and promethera hepascreen, among other …
  • Marcegaglia SpA:企業の戦略・SWOT・財務情報
    Marcegaglia SpA - Strategy, SWOT and Corporate Finance Report Summary Marcegaglia SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Fujitsu Limited (6702):企業の財務・戦略的SWOT分析
    Fujitsu Limited (6702) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • PT Apexindo Pratama Duta Tbk (APEX):企業の財務・戦略的SWOT分析
    PT Apexindo Pratama Duta Tbk (APEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Oaktree Capital Group Llc
    Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report Summary Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • PT Charoen Pokphand Indonesia Tbk (CPIN):企業の財務・戦略的SWOT分析
    PT Charoen Pokphand Indonesia Tbk (CPIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Richter Gedeon Nyrt (RICHTER):企業の財務・戦略的SWOT分析
    Richter Gedeon Nyrt (RICHTER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Ultra Clean Holdings Inc (UCTT):企業の財務・戦略的SWOT分析
    Summary Ultra Clean Holdings Inc (UCH) is a developer and supplier of critical systems and subsystems. The company’s products include precision robotic solutions, gas delivery systems, industrial and automation production equipment, chemical delivery modules, top-plate assemblies, wafer cleaning sub …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆